EP Patent

EP4366737A1 — Medicaments comprising glycosidase inhibitors

Assigned to Asceneuron SA · Expires 2024-05-15 · 2y expired

What this patent protects

The present invention relates to pharmaceutical compositions and medicaments comprising the compound of formula (I) (Formula I) or pharmaceutically usable solvates, salts or tautomers therof and dosage regimens for the administration thereof to human patients.

USPTO Abstract

The present invention relates to pharmaceutical compositions and medicaments comprising the compound of formula (I) (Formula I) or pharmaceutically usable solvates, salts or tautomers therof and dosage regimens for the administration thereof to human patients.

Drugs covered by this patent

Patent Metadata

Patent number
EP4366737A1
Jurisdiction
EP
Classification
—
Expires
2024-05-15
Drug substance claim
No
Drug product claim
No
Assignee
Asceneuron SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.